Redwood Investment Management LLC Grows Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Redwood Investment Management LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 287.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,107 shares of the company's stock after acquiring an additional 12,697 shares during the quarter. HCA Healthcare accounts for approximately 0.5% of Redwood Investment Management LLC's investment portfolio, making the stock its 27th biggest holding. Redwood Investment Management LLC's holdings in HCA Healthcare were worth $5,135,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the business. Barclays PLC increased its stake in shares of HCA Healthcare by 22.3% in the 3rd quarter. Barclays PLC now owns 571,975 shares of the company's stock worth $232,467,000 after acquiring an additional 104,409 shares during the last quarter. Eastern Bank acquired a new stake in HCA Healthcare during the 4th quarter worth approximately $62,000. Miracle Mile Advisors LLC acquired a new position in HCA Healthcare during the 4th quarter worth $385,000. Marcum Wealth LLC raised its holdings in HCA Healthcare by 14.6% in the fourth quarter. Marcum Wealth LLC now owns 706 shares of the company's stock valued at $212,000 after acquiring an additional 90 shares in the last quarter. Finally, Oak Thistle LLC grew its stake in shares of HCA Healthcare by 1,042.9% during the fourth quarter. Oak Thistle LLC now owns 7,040 shares of the company's stock worth $2,113,000 after purchasing an additional 6,424 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Cantor Fitzgerald restated an "overweight" rating and set a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. StockNews.com upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Monday, April 28th. Royal Bank of Canada reduced their target price on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Bank of America lowered their price objective on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research report on Monday, January 27th. Finally, Barclays dropped their price objective on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $381.13.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $366.98 on Thursday. The company's 50-day moving average is $338.45 and its two-hundred day moving average is $328.35. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a market cap of $88.29 billion, a PE ratio of 16.70, a PEG ratio of 1.10 and a beta of 1.46.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The business's quarterly revenue was up 5.7% on a year-over-year basis. During the same period last year, the company posted $5.36 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.78%. HCA Healthcare's dividend payout ratio is 12.81%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the business's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. The trade was a 38.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.